Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

R. Donken; J. Hoes; M. J. Knol; G. S. Ogilvie; S. Dobson; A. J. King; J. Singer; P. J. Woestenberg; J. A. Bogaards; C. J. L. M. Meijer; H. E. de Melker

doi:10.1186/s12879-020-05083-7

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

R. Donken^*, J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer, H. E. de Melker

^*Corresponding author for this work

CAPHRI - Health Inequities and Societal Participation

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	482
Number of pages	11
Journal	BMC Infectious Diseases
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s12879-020-05083-7
Publication status	Published - 8 Jul 2020

Keywords

Human papillomavirus
HPV
Persistent infection
HPV vaccination
Follow-up
HPV-16/18 AS04-ADJUVANTED VACCINE
HUMAN-PAPILLOMAVIRUS TYPE-16
CROSS-PROTECTIVE EFFICACY
PATRICIA RANDOMIZED-TRIAL
SUSTAINED EFFICACY
DOUBLE-BLIND
PARTICLE VACCINE
YOUNG-WOMEN
FOLLOW-UP
CERVICAL COINFECTION

Access to Document

10.1186/s12879-020-05083-7

Cite this

Donken, R., Hoes, J., Knol, M. J., Ogilvie, G. S., Dobson, S., King, A. J., Singer, J., Woestenberg, P. J., Bogaards, J. A., Meijer, C. J. L. M., & de Melker, H. E. (2020). Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches. BMC Infectious Diseases, 20(1), [482]. https://doi.org/10.1186/s12879-020-05083-7

@article{14063c2bc86140be80c55e12da349369,

title = "Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches",

keywords = "Human papillomavirus, HPV, Persistent infection, HPV vaccination, Follow-up, HPV-16/18 AS04-ADJUVANTED VACCINE, HUMAN-PAPILLOMAVIRUS TYPE-16, CROSS-PROTECTIVE EFFICACY, PATRICIA RANDOMIZED-TRIAL, SUSTAINED EFFICACY, DOUBLE-BLIND, PARTICLE VACCINE, YOUNG-WOMEN, FOLLOW-UP, CERVICAL COINFECTION",

author = "R. Donken and J. Hoes and Knol, {M. J.} and Ogilvie, {G. S.} and S. Dobson and King, {A. J.} and J. Singer and Woestenberg, {P. J.} and Bogaards, {J. A.} and Meijer, {C. J. L. M.} and {de Melker}, {H. E.}",

year = "2020",

month = jul,

day = "8",

doi = "10.1186/s12879-020-05083-7",

language = "English",

volume = "20",

journal = "BMC Infectious Diseases",

issn = "1471-2334",

publisher = "BioMed Central Ltd",

number = "1",

}

Measuring vaccine effectiveness against persistent HPV infections : a comparison of different statistical approaches. / Donken, R.; Hoes, J.; Knol, M. J.; Ogilvie, G. S.; Dobson, S.; King, A. J.; Singer, J.; Woestenberg, P. J.; Bogaards, J. A.; Meijer, C. J. L. M.; de Melker, H. E.

In: BMC Infectious Diseases, Vol. 20, No. 1, 482, 08.07.2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Measuring vaccine effectiveness against persistent HPV infections

T2 - a comparison of different statistical approaches

AU - Donken, R.

AU - Hoes, J.

AU - Knol, M. J.

AU - Ogilvie, G. S.

AU - Dobson, S.

AU - King, A. J.

AU - Singer, J.

AU - Woestenberg, P. J.

AU - Bogaards, J. A.

AU - Meijer, C. J. L. M.

AU - de Melker, H. E.

PY - 2020/7/8

Y1 - 2020/7/8

KW - Human papillomavirus

KW - HPV

KW - Persistent infection

KW - HPV vaccination

KW - Follow-up

KW - HPV-16/18 AS04-ADJUVANTED VACCINE

KW - HUMAN-PAPILLOMAVIRUS TYPE-16

KW - CROSS-PROTECTIVE EFFICACY

KW - PATRICIA RANDOMIZED-TRIAL

KW - SUSTAINED EFFICACY

KW - DOUBLE-BLIND

KW - PARTICLE VACCINE

KW - YOUNG-WOMEN

KW - FOLLOW-UP

KW - CERVICAL COINFECTION

U2 - 10.1186/s12879-020-05083-7

DO - 10.1186/s12879-020-05083-7

M3 - Article

C2 - 32640998

VL - 20

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 482

ER -